Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Magnesium chloride + sodium acetate + potassium chloride + sodium gluconate** is an unspecified multi-electrolyte combination intended for parenteral fluid and electrolyte replacement. The component salts would provide magnesium, potassium, sodium, chloride, acetate, and gluconate ions; acetate can be metabolized to bicarbonate equivalents and contribute to acid-base buffering. However, this exact four-ingredient composition is not a confirmed unique marketed product from the public labels reviewed. In particular, Plasma-Lyte A, Plasma-Lyte 148, Normosol-R, and Isolyte S contain the same four named salts **plus sodium chloride**, and therefore are not exact aliases of the requested composition. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ec9e61c-2c26-402f-8604-f446b2e34058))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + sodium acetate + potassium chloride + sodium gluconate.